is there a patent on semaglutide Last week's expiry of the for semaglutide—the active ingredient in Novo Nordisk's blockbuster drugs that are used to treat both diabetes and obesity—unleashed flurry of launches of low-cost generic versions 2026-2031 | THE 5-YEAR PLAN
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
























